Geno Focus Inc. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
147
2,182
1,211
1,615
1,343
Depreciation, Depletion & Amortization
80
92
149
357
1,229
Other Funds
49
649
130
47
339
Funds from Operations
276
1,625
1,230
2,019
2,911
Changes in Working Capital
706
1,993
1,624
1,503
1,547
Net Operating Cash Flow
431
368
2,854
516
1,364
Capital Expenditures
700
6,235
9,621
5,462
4,582
Sale of Fixed Assets & Businesses
-
197
12
-
-
Purchase/Sale of Investments
31
42
795
32,521
12,366
Net Investing Cash Flow
732
5,616
10,747
38,311
1,204
Issuance/Reduction of Debt, Net
4,265
143
937
-
2,130
Net Financing Cash Flow
6,765
4,857
11,955
30,976
1,874
Net Change in Cash
5,602
1,107
4,008
6,803
671
Free Cash Flow
646
5,049
5,271
3,653
700
Net Assets from Acquisitions
-
-
-
-
5,038
Other Sources
-
464
59
-
127
Change in Capital Stock
2,500
5,000
12,892
30,976
256
Exchange Rate Effect
1
21
54
15
23
Other Uses
-
-
402
328
1,669

About Geno Focus

View Profile
Address
Unit 201, Migun Techno World II
Daejeon DE 34014
Korea, Republic Of
Employees -
Website http://www.genofocus.com
Updated 09/14/2018
GenoFocus, Inc. engages the research and development of technologies related to biochemical and biotechnology industry. Its products include enzymes for food, animal, bioconversion and edible vaccines. In addition, It also provides technical services such as library generation, high-throughput screening and consulting services.